Legend:
CC = Baltimore Convention Center,
H = Hilton Baltimore
* = applied session ! = JSM meeting theme
Activity Details
29 * !
Sun, 7/30/2017,
2:00 PM -
3:50 PM
CC-320
Bayesian Methods and Applications in Clinical Trials (I) — Contributed Papers
Biopharmaceutical Section
Chair(s): Jagadish Gogate, Johnson & Johnson
2:05 PM
Statistical Innovations on Safety Analyzes
—
Shuai Yuan, Merck ; William W Wang, Merck & Co Inc
2:20 PM
Statistical Monitoring of Safety via a Bayesian Predictive Approach
—
LiAn Lin ; Greg Ball, Merck ; William W Wang, Merck & Co Inc
2:35 PM
Bayesian Methods for Analysis of Biosimilar Phase III Trials
—
Robert Weiss, UCLA Fielding School of Public Health ; Xiaomao Simon Xia, University of Missouri ; Nan Zhang, Amgen Inc ; Hui Wang, Amgen Inc ; Eric Chi, Amgen, Inc.
2:50 PM
Comparing ITT Estimates with Adherence Adjusted Estimates Based on the Rubin Causal Model
—
Sreelatha Meleth, RTI International ; Barry Eggleston, RTI International
3:05 PM
Borrowing Historical Information for Clinical Development - a Case Study
—
Guochen Song, Biogen ; Peng Sun, Biogen ; John Zhong, Biogen ; Jie Li, Biogen ; Baoguang Han, Biogen ; Stacy Lindborg, Biogen
3:20 PM
Expanding the Role of N-Of-1 Trials in Regulated Clinical Trials
—
Samuel Dickson, USAMMDA Biostatistics Branch ; Sharon A Gilbert, USAMMDA Biostatistics Branch ; Cynthia V. Landefeld, USAMMDA Biostatistics Branch ; Nan Guo, USAMMDA Biostatistics Branch ; William F. McCarthy, USAMMDA Biostatistics Branch
3:35 PM
Floor Discussion